A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy

• Glavni autori: Cristina Ioana Barbălată (Autor), Alina Silvia Porfire (Autor), Alina Sesarman (Autor), Valentin-Florian Rauca (Autor), Manuela Banciu (Autor), Dana Muntean (Autor), Rareș Știufiuc (Autor), Alin Moldovan (Autor), Cristian Moldovan (Autor), Ioan Tomuță (Autor)
• Format: Knjiga
• Izdano: MDPI AG, 2021-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

An increasing number of studies published so far have evidenced the benefits of Simvastatin (SIM) and Doxorubicin (DOX) co-treatment in colorectal cancer. In view of this, the current study aimed to investigate the pharmaceutical development of liposomes co-encapsulating SIM and DOX, by implementing...